217 results
8-K/A
EX-99.1
VNDA
Vanda Pharmaceuticals Inc
16 Feb 24
Special Purpose Abbreviated Financial Statements
4:31pm
States of America.
Basis for Opinion
We conducted our audit in accordance with auditing standards generally accepted in the United States of America … (US GAAS). Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Special Purpose
8-K/A
EX-99.2
VNDA
Vanda Pharmaceuticals Inc
16 Feb 24
Special Purpose Abbreviated Financial Statements
4:31pm
have not been included in these Financial Statements. These costs comprise of employee related costs, legal, audit and consultancy fees and other costs
8-K
EX-3.1
4hxhxbshksc
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:15pm